Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Both mouse and rat models are effective for testing alopecia areata treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Prolactin may be important for skin growth and immune function.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Non-immune factors play a significant role in alopecia areata.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Genomic approach finds new possible treatments for hair loss.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Epidermal stem cells have potential for personalized regenerative medicine but need careful handling to avoid cancer.

Scientists found the best time to transplant human stem cells for hair growth is between days 16-18 when they have the right markers and growth potential.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Low-level laser therapy may help stem cells grow and function better, aiding in healing and tissue repair.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

When skin blisters, healing the wound is more important than growing hair, and certain stem cells mainly fix the blisters without helping hair growth.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.